CrowdStrike’s (CRWD) “Neutral” Rating Reiterated at Guggenheim
otakuyassine3@gmail.com Guggenheim reissued their neutral rating on shares of CrowdStrike (NASDAQ:CRWD – Free Report) in a...
Guggenheim
Neurocrine Biosciences (NASDAQ:NBIX) Given New $163.00 Price Target at Guggenheim
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target decreased by stock analysts...
Evergy (NASDAQ:EVRG) Upgraded at Guggenheim
Guggenheim upgraded shares of Evergy (NASDAQ:EVRG – Free Report) from a neutral rating to a...
MongoDB (NASDAQ:MDB) Upgraded to “Buy” at Guggenheim
MongoDB (NASDAQ:MDB – Get Free Report) was upgraded by Guggenheim from a “neutral” rating to...